期刊文献+

游离脂肪酸和铁诱导非酒精性脂肪肝病的协同作用机制研究 被引量:2

Study of synergistic effect of free fatty acid and iron on the establishment of nonalcoholic fatty liver disease model
原文传递
导出
摘要 目的采用游离脂肪酸(FFA)和Fe^2+诱导肝细胞建立非酒精性脂肪肝病(NAFLD)模型,探讨FFA和Fe^2+在NAFLD发病过程中是否具有协同作用及其作用机制。方法设置对照组(细胞正常培养),0.250、0.500、1.000mmol/L油酸组,以及0.500mmol/L油酸+0.125mmol/L Fe^2+、0.500mmol/L油酸+0.250mmol/L Fe^2+、0.500mmol/L油酸+0.500mmol/L Fe^2+组,分别处理人肝癌HepG2细胞,采用油红O染色观察细胞脂质沉积,以磷酸甘油氧化酶法(GPO—PAP)测定细胞内TG的含量,采用RT—PCR法检测脂肪酸β-氧化的关键基因[脂酰CoA合成酶(ACSL-1)、肉碱棕榈酰基转移酶(CPT-1a)、脂肪酸合成酶(FAS)]的表达。分析不同组别TG含量,以及ACSL-1、CPT-1a、FAS mRNA相对值的差异。结果油红0染色结果显示,浓度为0.500mmol/L的油酸分别与不同浓度Fe^2+共同处理HepG2细胞后,随着Fe^2+浓度的增加,细胞内脂滴含量逐渐增多。对照组、0.250、0.500、1.000mmol/L油酸、0.500mmol/L油酸+0.125mmol/L Fe^2+、0.500mmol/L油酸+0.250mmol/L Fe^2+、0.500mmol/L油酸+0.500mmol/L Fe^2+组HepG2细胞中TG含量分别为(90.0±1.6)、(131.7±5.4)、(153.7±3.0)、(254.1±4.0)、(164.5±6.0)、(180.1±7.7)、(235.6±4.5)nmo]/mg(F=396.00,P〈0.05)。0.500mmol/L油酸、0.500mmol/L油酸+0.125mmol/L Fe^2+、0.500mmol/L油酸+0.250mmol/L Fe^2+、0.500mmol/L油酸+0.500mmol/L Fe^2+组HepG2细胞ACSL-1mRNA的表达水平分别为0.94±0.02、0.89±0.04、0.85±0.02、0.74±0.04(F=50.00,P〈0.05),CPT-1a mRNA分别为0.89±0.03、0.79±0.05、0.67±0.04、0.51±0.05(F=79.00,P〈0.05);FAS mRNA分别为1.31±0.05、1.44±0.03、1.51±0.05、1.56±0.06(F=79.70,P〈0.05)。结论用一定浓度的FFA和Fe^2+培养HepG2细胞,能够诱导NAFLD模型,二者可能通过影响脂肪酸的β-氧化共同参与NAFLD的发病过程。 Objective To establish nonalcoholic fatty liver disease (NAFLD) model induced by free fatty acid (FFA) and iron, and to explore the synergistic effect of FFA and Fe^2+ on the pathogenesis of NAFLD and mechanisms. Methods Human liver carcinoma cell HepG2 was respectively treated with 0. 250, 0. 500, 1. 000 mmol/L oleic acid, 0. 500 mmol/L oleic acid +0. 125 mmol/L Fe^2+ , O. 500 mmol/L oleic acid + 0. 250 mmol/L Fe^2+ , and 0. 500 mmol/L oleic acid + 0. 500 mmol/L Fe^2+ . Human liver carcinoma cell HepG2 was normally cultured in the control group. Lipid accumulation of cells were observed by oil red O staining and the determination of the triglyceride (TG) contents by GPO-PAP, then the expression of key genes involved in fatty acid β-oxidation ( fatty acyl CoA synthetase-1 ( ACSL-1 ) , carnitine acyl transferase 1 (CPT-1a), fatty acid synthetase (FAS)) was determined using RT-PCR. The differences of TG content and ACSL-1, CPT-1a, FAS, mRNA relative value were analyzed among different groups. Results The results of oil red O staining indicated that the eontents of lipid droplets were obviously elevated with the increase of Fe^2+ concentration in human liver carcinoma cell HepG2 treated with 0. 500 mmol/L oleic acid and different concentrations of Fe^2+ . The TG contents of HepG2 cell in control group, 0. 250, 0. 500, 1. 000 mmol/L oleie acid groups, 0. 500 mmol/L oleic acid +0. 125 mmol/L Fe^2+ group, 0. 500 mmol/L oleic acid + 0. 250 mmol/L Fe^2+ group, 0. 500 mmol/L oleic acid + 0. 500 mmol/L Fe^2+ group respectively were (90.0±1.6), (131.7 ±5.4), (153.7 ±3.0) , (254. 1 24.0), (164.5 ±6.0), (180. 1 ±7.7), (235.6±4.5) nmol/mg (F =396.00, P 〈0.05). The expression levels of ACSL-1 mRNA in 0. 500 mmol/L oleic acid group, 0. 500 mmol/L oleic acid +0. 125 mmol/L Fe^2+ group, 0. 500 mmol/L oleic acid + 0. 250 mmol/L Fe2 ± group, 0. 500 mmol/L oleic acid + 0. 500 mmol/L Fe^2 + group respectively were ( 0. 94 ± 0. 02 ), ( 0. 89 ±0. 04 ), ( 0. 85 ±0. 02 ), ( 0. 74 ±0. 04 ) ( F = 50. 00, P 〈 0. 05) ; the mRNA levels of CPT-1a were (0. 89 ±0. 03), (0. 79 ±0. 05), (0. 67±0. 04), (0. 51±0. 05) (F=79.00,P〈0.05); the mRNAlevels of FAS were (1.31±0.05),(1.44±0.03),(1.51 ±0.05), ( 1.56 ± 0. 06 ) ( F = 79. 70, P 〈 0. 05 ). Conclusion The NAFLD liver cell model could be established by oleic acid and Fe^2 + in HepG2 cells. FFA and iron might be involved in the pathogenesis of NAFLD through the intervention of fatty acid β-oxidation.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2014年第10期904-908,共5页 Chinese Journal of Preventive Medicine
基金 国家自然科学基金(81273062)
关键词 油酸 脂肪肝 铁超负荷 脂肪酸类 Oleic acid Fatty liver Iron overload Fatty acids
  • 相关文献

参考文献18

  • 1Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[ J]. J Gastroenterol Hepatol,2013,28 Suppl 1: S11-17.
  • 2Farrell GC, Wong VW, Chitturi S. NAFLD in Asia - as common and important as in the West[ J]. Nat Rev Gastroenterol Hepatol, 2013,10(5) :307-318.
  • 3李琪,王晓峰,马向华.铁超负荷与胰岛素抵抗的相关性研究进展[J].医学综述,2008,14(13):1932-1934. 被引量:4
  • 4WANG LiDong1, ZHOU Qi1, WEI JunPing1, YANG WanCai1, ZHAO Xin1, WANG LiXia1, ZOU Jian Xiang1, GAO ShanShan1, LI YongXin1 and YANG C.S.2Keywords esophageal neoplasms,apoptosis,precancerous lesions,Waf1 p21 gene,p53.Apoptosis and its relationship with cell proliferation,p53,Waf1p21,bcl-2 and c-mycin esophageal carcinogenesis studied with a high-risk population in northern China[J].World Journal of Gastroenterology,1998,4(4):15-21. 被引量:298
  • 5Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis : human data [ J ]. Clin Liver Dis, 2007,11 ( 1 ) : 75-104.
  • 6Okamoto Y, Tanaka S, Haga Y. Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model [ J ]. Hepatol Res, 2002,23 (2) : 138-144.
  • 7Boden G. Obesity, insulin resistance and free fatty acids [ J ]. Curr Opin Endocrinol Diabetes Obes,2011,18 (2) : 139-143.
  • 8孙冬玲,顾东风.代谢综合征的定义及其流行病学[J].中华预防医学杂志,2006,40(2):133-135. 被引量:89
  • 9Yao HR, Liu J, Plumeri D, et al. Lipotoxicity in HepG2 cells triggered by free fatty acids[ J]. Am J Transl Res,2011,3 (3) : 284-291.
  • 10Fujimoto Y,Onoduka J, Homma KJ, et al. Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase [ J ]. Biol Pharm Bull, 2006,29( 11 ) :2174-2180.

二级参考文献24

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3044
  • 2向红丁,陈伟,张晓林,方京徽.北京市东城区居民代谢综合征状况的调查[J].中国糖尿病杂志,2004,12(3):169-172. 被引量:43
  • 3周北凡,武阳丰,李莹,张林峰.中国成人代谢综合征腰围切点的研究[J].中华心血管病杂志,2005,33(1):81-85. 被引量:81
  • 4顾东风,Reynolds K,杨文杰,陈恕凤,吴锡桂,段秀芳,蒲晓东,徐丽华,吴先萍,陈祥福,魏仁敏,陈娜萦,吴天一,王礼桂,姚才良,牟建军,马义峰,王晓飞,Whelton P,何江.中国成年人代谢综合征的患病率[J].中华糖尿病杂志(1006-6187),2005,13(3):181-186. 被引量:580
  • 5谭少珍,周智广,唐炜立,陈小燕,颜湘,汤佳珍,彭健,黄干,冯琼,刘玉华.代谢综合征三种诊断标准在2型糖尿病中的比较研究[J].中华糖尿病杂志(1006-6187),2005,13(3):187-189. 被引量:22
  • 6Fuch J, Podda M, Pacher L, et al. Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes [ J ]. Toxicology, 2002,180(2) :169-181.
  • 7Hramiak IM, Finegood DT, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis [ J ]. Clin Invest Med, 1997,20(4) :110-118.
  • 8Niederau C, Strohmeyer G. Strtegies for early diagnosis of haemochromatosis [J ]. Eur J Gastroenterol Hepatol, 2002, 14 ( 3 ) : 223 -229.
  • 9Carlo H, Holl RW, Debatin KW, et al. Insulin Sensitivity and bete- cell secretion in thalassaemia major with secondary haemochromatosis : assessment by oral glucose tolerance test [ J ]. Eur J Pediatr, 2003,162(3) :139-146.
  • 10Chem JP, Lin KH, Lu MY, et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients [ J ]. Diabetes Care,2001,24 (3) :850-854.

共引文献388

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部